From Stigma to Solutions: A Collaborative Healthcare Team Approach to Erectile Dysfunction
Target Audience: Pharmacist, Pharmacy Tech, Physician Assistant, Physician
Course Overview
Erectile dysfunction (ED) is the inability to maintain or achieve an erection satisfactory for intercourse. It is the most common cause of sexual dysfunction among men in the United States (US). An estimated 50% of men will experience some form of ED in their lifetime, making this a significant medical problem. Patients with ED require a patient-centered, holistic approach to care that involves treating underlying conditions and improving the quality and number of erections while avoiding medication side effects. Primary care providers are often the first to assess and initiate evaluation, making them critical in identifying underlying contributors such as diabetes, hypertension, or depression. Healthcare team members can also provide crucial counseling on the appropriate use of ED medications and help patients to mitigate side effects and avoid harmful drug interactions. This course will review the etiology and pathophysiology of ED and describe available treatment options in detail, including appropriate administration, mechanisms of action, side effects, and contraindications.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Describe the prevalence and underlying causes of erectile dysfunction
- Compare and contrast phosphodiesterase-5 inhibitors
- Recall indications, contraindications, side effect profiles, and monitoring parameters for erectile dysfunction treatments
- Identify the roles of healthcare team members in the management of erectile dysfunction
Faculty
- Introduction
- Etiology and Risk Factors
- Pathophysiology of Erectile Dysfunction
- Diagnosing Erectile Dysfunction
- Evidence-Based Management of Erectile Dysfunction
- AUA Reaffirmation
- Goals of Treatment
- Treating Psychogenic ED
- Lifestyle Interventions as a Foundation of ED Management
- Phosphodiesterase-5 Inhibitors
- Mechanism of Action and Pharmacokinetics
- Dosing and Optimization
- Adverse Effects
- Patient Monitoring and Counseling
- PDE5i Efficacy
- Emerging and Nontraditional Benefits
- Prostaglandin E1
- Mechanism of Action and Dosing
- Intracavernosal Administration
- Adverse Reactions
- Patient Monitoring
- Alprostadil Efficacy
- Testosterone
- Advances in Non-Oral and Regenerative Therapies for Erectile Dysfunction
- Summary
- Disclosures
From March 18, 2026 through March 18, 2029, participants must:
- Read the "learning objectives" and "author and planning team disclosures"
- Study the section entitled "educational activity"
- Complete the Course Test and Evaluation form. The Course Test will be graded automatically. Following successful completion of the Course Test with a score of 70% or higher, a statement of participation will be made available immediately. (No partial credit will be given.)
Credit for this course will be automatically uploaded to CPE Monitor®.
Faculty Planner Disclosure
The following individuals were involved in planning, developing, and/or authoring this activity: L. Austin Fredrickson, MD, FACP; Kristina (Tia) Neu, RN; and Pamela Sardo, PharmD, BS. None of the individuals involved in developing this activity has a conflict of interest or financial relationships related to the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.
Unlabeled Use Disclosure
The information provided in this course is general in nature, and it is designed solely to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant's professional practice, including but not limited to patient assessment, diagnosis, treatment, and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals must consult their employer, healthcare facility, hospital, or other organization for guidelines, protocols, and procedures to follow. The information provided in this course does not replace those guidelines, protocols, and procedures, but is for academic purposes only, and this course's limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses is constantly changing. Any person taking this course understands that such a person must make an independent review of medication information before any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only, and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course or course material.
Please ensure the device you plan to use meets these requirements:
- Operating System: Windows 7, 8, 10, or 11 / Mac OS X 10.9 or later / iOS / Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
Accreditation
In support of improving patient care, RxCE.com is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PTCB Recognition
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".